Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This update does not alter the study details or page content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.2 was added; the earlier notice about government funding status (v3.4.1) was removed.SummaryDifference0.3%

- Check68 days agoChange DetectedAdded a public notice about potential disruptions due to a lapse in government funding and the NIH Clinical Center's operating status, with a link to opm.gov. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check75 days agoChange DetectedThis update adds a Show glossary option and updates footer/QC-related labels (including a new Revision: v3.4.0) and related wording, while removing the older QC-label phrasing and No FEAR Act data wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4—a minor backend change with no impact on study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.